Will AbbVie's Acquisition Spree Aid Pipeline Growth?

AbbVie ABBV has been actively ramping up its deal-making efforts lately, thereby strengthening its pipeline. While immunology remains its core area, the company is also signing some early-stage deals across various other therapeutic areas, including oncology and neuroscience.Earlier this week, AbbVie signed a definitive agreement to acquire privately held biotech...